Cargando…

A crucial role for HVEM and BTLA in preventing intestinal inflammation

The interaction between the tumor necrosis factor (TNF) family member LIGHT and the TNF family receptor herpes virus entry mediator (HVEM) co-stimulates T cells and promotes inflammation. However, HVEM also triggers inhibitory signals by acting as a ligand that binds to B and T lymphocyte attenuator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steinberg, Marcos W., Turovskaya, Olga, Shaikh, Raziya B., Kim, Gisen, McCole, Declan F., Pfeffer, Klaus, Murphy, Kenneth M., Ware, Carl F., Kronenberg, Mitchell
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2008
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413041/ https://www.ncbi.nlm.nih.gov/pubmed/18519647 http://dx.doi.org/10.1084/jem.20071160

Ejemplares similares

BTLA Interaction with HVEM Expressed on CD8(+) T Cells Promotes Survival and Memory Generation in Response to a Bacterial Infection
por: Steinberg, Marcos W., et al.
Publicado: (2013)

CD8 T Cell Memory to a Viral Pathogen Requires Trans Cosignaling between HVEM and BTLA
por: Flynn, Rachel, et al.
Publicado: (2013)

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)

Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding
por: Spodzieja, Marta, et al.
Publicado: (2020)

Attenuation of the BTLA/HVEM Regulatory Network in the Circulation in Primary Sjögren’s Syndrome
por: Small, Annabelle, et al.
Publicado: (2022)

The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis
por: Mintz, Michelle A., et al.
Publicado: (2019)

HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160
por: Liu, Weifeng, et al.
Publicado: (2021)

Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis
por: Lan, Xiuwen, et al.
Publicado: (2017)

BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
por: Demerlé, Clemence, et al.
Publicado: (2021)

Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses
por: Spodzieja, Marta, et al.
Publicado: (2017)

BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection
por: Yu, Xueping, et al.
Publicado: (2019)

The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis
por: Yang, Bin, et al.
Publicado: (2016)

BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2021)

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
por: Demerlé, Clémence, et al.
Publicado: (2023)

Btla signaling in conventional and regulatory lymphocytes coordinately tempers humoral immunity in the intestinal mucosa
por: Stienne, Caroline, et al.
Publicado: (2022)

Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Publicado: (2023)

Correction: The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis
por: Yang, Bin, et al.
Publicado: (2017)

The BTLA–HVEM–CD5 Immunoregulatory Axis–An Instructive Mechanism Governing pTreg Cell Differentiation
por: Bourque, Jessica, et al.
Publicado: (2019)

Fragments of gD Protein as Inhibitors of BTLA/HVEM Complex Formation - Design, Synthesis, and Cellular Studies
por: Kuncewicz, Katarzyna, et al.
Publicado: (2020)

The HVEM-BTLA Immune Checkpoint Restrains Murine Chronic Cholestatic Liver Injury by Regulating the Gut Microbiota
por: Kou, Yanbo, et al.
Publicado: (2022)

The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
por: Xu, Huan, et al.
Publicado: (2012)

Distinct Changes of BTLA and HVEM Expressions in Circulating CD4(+) and CD8(+) T Cells in Hepatocellular Carcinoma Patients
por: Liu, Jiayu, et al.
Publicado: (2018)

Allosteric regulation of binding specificity of HVEM for CD160 and BTLA ligands upon G89F mutation
por: Shrestha, Rojan, et al.
Publicado: (2021)

Associations between HVEM/LIGHT/BTLA/CD160 polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipients
por: Wang, Zijie, et al.
Publicado: (2017)

HVEM is a TNF Receptor with Multiple Regulatory Roles in the Mucosal Immune System
por: Shui, Jr-Wen, et al.
Publicado: (2014)

Lymphocyte HVEM/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppression
por: Wakeley, Michelle E., et al.
Publicado: (2023)

LIGHT–HVEM signaling in keratinocytes controls development of dermatitis
por: Herro, Rana, et al.
Publicado: (2018)

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2023)

Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli
por: Shawki, Ali, et al.
Publicado: (2016)

NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of Vα14i NKT Cells
por: Elewaut, Dirk, et al.
Publicado: (2003)

HVEM Signalling Promotes Colitis
por: Schaer, Corinne, et al.
Publicado: (2011)

JAK-STAT Pathway Regulation of Intestinal Permeability: Pathogenic Roles and Therapeutic Opportunities in Inflammatory Bowel Disease
por: Lei, Hillmin, et al.
Publicado: (2021)

All Hands on Deck: Commensals, Th17 Cells, and Neutrophils Provide Short-term Compensation of Constitutive Permeability Defects Against Acute Infection
por: McCole, Declan F.
Publicado: (2017)

Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy
por: Edwards, Rebecca G., et al.
Publicado: (2017)

Roles of BTLA in Immunity and Immune Disorders
por: Ning, Zhaochen, et al.
Publicado: (2021)

Blockade of HVEM for Prostate Cancer Immunotherapy in Humanized Mice
por: Aubert, Nicolas, et al.
Publicado: (2021)

Virtual Evolution of HVEM Segment for Checkpoint Inhibitor Discovery
por: Yu, Mingjia, et al.
Publicado: (2021)

Epithelial-microbial diplomacy: escalating border tensions drive inflammation in inflammatory bowel disease
por: King, Stephanie J, et al.
Publicado: (2019)

Lymphotoxin β Receptor: a Crucial Role in Innate and Adaptive Immune Responses against Toxoplasma gondii
por: Tersteegen, Anne, et al.
Publicado: (2021)

Modulation of LIGHT-HVEM Costimulation Prolongs Cardiac Allograft Survival
por: Ye, Qunrui, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_4plukvr02pph8isg9ghd82iidq